Role of Complement in Commensal Microbiota Actions Regulating Sketal Maturation
Role of Complement in Commensal Microbiota Actions Regulating Sketal Maturation
批准号:
10656406
负责人:
Jessica Diann Hathaway-Schrader
金额:
$0.0万
依托单位国家:
美国
项目类别:
财政年份:
2022
资助国家:
美国
项目状态:
未结题
起止时间:
2022-07-01 至 2027-06-30
关键词:
AdultAgeAgingAnaphylatoxinsAnimalsAreaBone DensityBone MarrowBone ResorptionC3AR1 geneCellsComplementComplement 3aComplement ReceptorDataDeteriorationDevelopmentDiseaseFunding MechanismsGerm-FreeGoalsGonadal Steroid HormonesGrowthHealthImmuneImmune responseImmune signalingImmunityImmunologic StimulationImpairmentIn VitroInfectionInflammatoryInflammatory Bowel DiseasesInterventionIntestinesKnowledgeLactobacillus plantarumLongevityMediatingMediatorMentorsModelingMusOsteoblastsOsteoclastsOsteopeniaOsteoporosisPathogenesisPhaseProbioticsProcessReportingResearchResearch PersonnelResourcesRiskRoleServicesSignal TransductionSkeletal DevelopmentSkeletonSolidSystemTestingTherapeutic InterventionTrainingTransgenic MiceUp-RegulationVeteransWorkage relatedagedbonebone cellbone fracture repairbone healthbone lossbone masscareercareer developmentcommensal microbesdeprivationdextran sulfate sodium induced colitisexperiencefracture riskgerm free conditiongut microbiotahost microbiotaimmunoregulationimprovedin vivoinnovationknock-downmicrobiotaosteoclastogenesisosteoimmunologypathogenic microbepostdoctoral investigatorreceptorrecruitservice memberskeletalskeletal maturationsubstantia spongiosatoolyoung adult
中文摘要
摘要
共生微生物群严格调节骨免疫过程介导青春期后骨骼
发展我们的研究表明小肠菌群抑制成骨细胞骨-
形成细胞,并增强骨吸收细胞,这会损害骨量增加。然而,在这方面,
在整个生命周期中辨别骨骼微生物群对骨骼的影响的机制尚不清楚。
骨免疫学的研究表明,骨髓中的免疫细胞调节骨
建模/重塑。尽管知道肠道微生物群引导与宿主的串扰,
免疫,阐明肠道微生物群免疫调节作用的免疫机制研究
骨骼成熟尚不清楚。研究人员博士后研究工作的初步结果表明,
肠道微生物-宿主相互作用刺激补体信号传导,
健康和疾病中的成熟骨骼。
补体信号传导保护宿主免受感染并调节免疫应答,
补体在维持体内微生物群平衡中的作用。我们
初步数据表明,肠道微生物群上调循环补体,
过敏毒素C3 a,其也与炎症性肠发病机制有关。补体受体
C3 aR在成骨细胞和破骨细胞上都有表达,这意味着C3 a可能是成骨细胞和破骨细胞的关键调节因子。
肠道微生物群对健康和疾病中骨骼成熟的影响。三个具体目标将解决
在成骨细胞和破骨细胞中使用C3 aR缺失的转基因小鼠进行的关键体内和体外研究,
健康和下葡聚糖硫酸钠(DSS)诱导的结肠炎。这三个目标将调查的整体
C3 a的肠道微生物群上调调节C3 aR衍生的骨骼成熟的假设
在健康和疾病的整个生命周期。目的1将阐明肠道微生物群在
正常和炎症条件下骨骼成熟和退化中C3 aR介导的成骨细胞生成
肠道状况目的2将检查在C3 aR-破骨细胞生成信号传导中的小肠肠道微生物群作用,
在健康和疾病中的成熟和衰老的骨骼。目标3将决定是否给予益生菌
在青春期后骨骼发育过程中调节C3 a/C3 aR信号传导。阐明以下方面的关系:
C3/C3 aR信号传导、肠道微生物群和骨骼将为治疗干预提供机会,
优化年轻军人的骨量增加,防止骨骼老化
老兵
这项研究旨在确定骨免疫学过程调节峰值骨量增加,
承受年龄相关和/或疾病相关的骨骼退化。这些研究将创新性地使用
骨细胞特异性C3 aR敲低模型,以确定微生物群衍生的补体信号传导对
骨骼成熟值得注意的是,这项工作提出了在峰值骨量增加窗口期间益生菌干预
为了确定骨骼微生物群对整个骨骼上补体C3 a/C3 aR的作用,
寿命此外,该提案将在新的专业知识和职业领域提供坚实的职业发展
申请人过渡到独立VA调查员所需的工具。这将是完成
通过CDA提供的拟议课程、实践培训、网络和指导经验,
2机制。
英文摘要
Abstract
Commensal microbiota critically regulates osteoimmune processes mediating post-pubertal skeletal
development. Our studies have shown that the commensal gut microbiota suppresses osteoblastic bone-
forming cells and enhances osteoclastic bone-resorbing cells, which impairs bone mass accrual. However,
mechanisms discerning commensal microbiota effects on bone across the lifespan are unclear.
The study of osteoimmunology has shown that immune cells in the bone marrow regulate bone
modeling/remodeling. Despite knowledge that the commensal gut microbiota directs crosstalk with host
immunity, immune mechanistic studies elucidating the commensal gut microbiota immunomodulatory effects on
skeletal maturation are unclear. Preliminary findings from the investigator’s postdoctoral research work suggest
that commensal microbiota-host interactions stimulate complement signaling to have system catabolic effects in
the maturing skeleton in health and disease.
Complement signaling protects the host from infection and modulates the immune response, highlighting
the role of complement in maintaining a homeostatic relationship with the commensal microbiota. Our
preliminary data demonstrated that the commensal microbiota upregulates circulating complement
anaphylatoxin C3a, which has also been implicated in inflammatory bowel pathogenesis. Complement receptor
C3aR is expressed on both osteoblasts and osteoclasts, implying that C3a may be a critical regulator of
commensal microbiota effects on the maturing skeleton in health and disease. Three specific aims will address
critical in vivo and in vitro studies utilizing transgenic mice deleting C3aR in both osteoblasts and osteoclasts in
health and under dextran sodium sulfate (DSS)-induced colitis. These three aims will investigate the overall
hypothesis that the commensal gut microbiota upregulation of C3a regulates C3aR derived skeletal maturation
in health and disease throughout the lifespan. Aim 1 will elucidate the role of commensal gut microbiota on
C3aR-mediated osteoblastogenesis in skeletal maturation and deterioration under normal and inflammatory
bowel conditions. Aim 2 will examine commensal gut microbiota actions on C3aR-osteoclastogenic signaling in
the maturing and aging skeleton in health and disease. Aim 3 will determine whether probiotic administration
regulates C3a/C3aR signaling during post-pubertal skeletal development. Elucidating the relationship between
C3/C3aR signaling, the gut microbiota, and bone will provide opportunities for therapeutic interventions to
optimize bone mass accrual in young service members and protect against skeletal deterioration in aging
Veterans.
This research seeks to define osteoimmunological processes regulating peak bone mass accrual to
withstand either age-related and/or disease-related skeletal deterioration. These studies will innovatively use
bone cells specific C3aR knockdown models to determine microbiota derived complement signaling effects on
skeletal maturation. Notably, this work proposes probiotic interventions during a peak bone mass accrual window
to define the role of the commensal microbiota on complement C3a/C3aR on the skeleton throughout the
lifespan. Additionally, this proposal will provide solid career development in new areas of expertise and career
tools necessary for the applicant's transition to an independent VA investigator. This will be accomplished
through proposed coursework, hands-on training, networking, and mentoring experiences provided by the CDA-
2 mechanism.
期刊论文(0)
专著(0)
科研奖励(0)
会议论文
国内基金
海外基金
登录
查看更多内容
补阳还五汤通过AGE-RAGE通路调控脓毒症免疫失衡的机制与转化研究
-
批准号:JCZRLH202601523
-
项目类别:省市级项目
-
资助金额:--
-
批准年份:2026
-
负责人:
-
依托单位:
靶向递送一氧化碳调控AGE-RAGE级联反应促进糖尿病创面愈合研究
-
批准号:JCZRQN202500010
-
项目类别:省市级项目
-
资助金额:--
-
批准年份:2025
-
负责人:
-
依托单位:
对香豆酸抑制AGE-RAGE-Ang-1通路改善海马血管生成障碍发挥抗阿尔兹海默病作用
-
批准号:2025JJ70209
-
项目类别:省市级项目
-
资助金额:--
-
批准年份:2025
-
负责人:雷芬芳
-
依托单位:
AGE-RAGE通路调控慢性胰腺炎纤维化进程的作用及分子机制
-
批准号:--
-
项目类别:面上项目
-
资助金额:--
-
批准年份:2024
-
负责人:万荣
-
依托单位:
甜茶抑制AGE-RAGE通路增强突触可塑性改善小鼠抑郁样行为
-
批准号:2023JJ50274
-
项目类别:省市级项目
-
资助金额:--
-
批准年份:2023
-
负责人:贺志明
-
依托单位:
蒙药额尔敦-乌日勒基础方调控AGE-RAGE信号通路改善术后认知功能障碍研究
-
批准号:--
-
项目类别:地区科学基金项目
-
资助金额:33万元
-
批准年份:2022
-
负责人:都义日
-
依托单位:
补肾健脾祛瘀方调控AGE/RAGE信号通路在再生障碍性贫血骨髓间充质干细胞功能受损的作用与机制研究
-
批准号:--
-
项目类别:面上项目
-
资助金额:52万元
-
批准年份:2022
-
负责人:叶宝东
-
依托单位:
LncRNA GAS5在2型糖尿病动脉粥样硬化中对AGE-RAGE 信号通路上相关基因的调控作用及机制研究
-
批准号:
-
项目类别:省市级项目
-
资助金额:10.0万元
-
批准年份:2022
-
负责人:于海兵
-
依托单位:
围绕GLP1-Arginine-AGE/RAGE轴构建探针组学方法探索大柴胡汤异病同治的效应机制
-
批准号:81973577
-
项目类别:面上项目
-
资助金额:55.0万元
-
批准年份:2019
-
负责人:辛贵忠
-
依托单位:
AGE/RAGE通路microRNA编码基因多态性与2型糖尿病并发冠心病的关联研究
-
批准号:81602908
-
项目类别:青年科学基金项目
-
资助金额:18.0万元
-
批准年份:2016
-
负责人:刘括
-
依托单位: